Protara Therapeutics Inc (TARA)
3.74
+0.03
(+0.81%)
USD |
NASDAQ |
May 16, 16:00
3.74
0.00 (0.00%)
After-Hours: 05:53
Protara Therapeutics Price to Book Value: 1.318 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 1.318 |
| May 15, 2024 | 1.308 |
| May 14, 2024 | 1.178 |
| May 13, 2024 | 1.142 |
| May 10, 2024 | 1.058 |
| May 09, 2024 | 1.050 |
| May 08, 2024 | 0.9977 |
| May 07, 2024 | 1.012 |
| May 06, 2024 | 1.022 |
| May 03, 2024 | 1.026 |
| May 02, 2024 | 1.019 |
| May 01, 2024 | 1.033 |
| April 30, 2024 | 1.050 |
| April 29, 2024 | 1.092 |
| April 26, 2024 | 1.031 |
| April 25, 2024 | 1.075 |
| April 24, 2024 | 0.9936 |
| April 23, 2024 | 1.057 |
| April 22, 2024 | 1.075 |
| April 19, 2024 | 0.9302 |
| April 18, 2024 | 0.9689 |
| April 17, 2024 | 0.9619 |
| April 16, 2024 | 1.004 |
| April 15, 2024 | 1.001 |
| April 12, 2024 | 1.057 |
| Date | Value |
|---|---|
| April 11, 2024 | 1.089 |
| April 10, 2024 | 1.124 |
| April 09, 2024 | 0.6304 |
| April 08, 2024 | 0.6715 |
| April 05, 2024 | 0.7106 |
| April 04, 2024 | 0.787 |
| April 03, 2024 | 0.8026 |
| April 02, 2024 | 0.8046 |
| April 01, 2024 | 0.8105 |
| March 28, 2024 | 0.6711 |
| March 27, 2024 | 0.6694 |
| March 26, 2024 | 0.6945 |
| March 25, 2024 | 0.6677 |
| March 22, 2024 | 0.6728 |
| March 21, 2024 | 0.6527 |
| March 20, 2024 | 0.6744 |
| March 19, 2024 | 0.6694 |
| March 18, 2024 | 0.6694 |
| March 15, 2024 | 0.6159 |
| March 14, 2024 | 0.5975 |
| March 13, 2024 | 0.6108 |
| March 12, 2024 | 0.5975 |
| March 11, 2024 | 0.5975 |
| March 08, 2024 | 0.6359 |
| March 07, 2024 | 0.6371 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1661
Minimum
Nov 22 2023
5.478
Maximum
Jun 02 2020
0.7613
Average
0.4285
Median
Price to Book Value Benchmarks
| AngioDynamics Inc | 1.176 |
| Regulus Therapeutics Inc | 1.217 |
| Bio-Path Holdings Inc | 3.602 |
| Outset Medical Inc | 1.954 |
| AN2 Therapeutics Inc | 0.6122 |
Price to Book Value Related Metrics
| Price | 3.74 |
| Earnings Yield | -100.0% |
| Market Cap | 77.01M |